参考文献/References:
[1] Writing Committee Members;Joglar JAChung MK,et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation:a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. J Am Coll Cardiol,2024,83(1):109-279.
[2] Olshansky B,Rosenfeld LE,Warner AL,et al. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study:approaches to control rate in atrial fibrillation[J]. J Am Coll Cardiol,2004,43(7):1201-1208.
[3] Freeman JV,Reynolds K,Fang M,et al. Digoxin and risk of death in adults with atrial fibrillation:the ATRIA-CVRN study[J]. Circ Arrhythm Electrophysiol,2015,8(1):49-58.
[4] Koruth JS,Lala A,Pinney S,et al. The clinical use of ivabradine[J]. J Am Coll Cardiol,2017,70(14):1777-1784.
[5] 中国医师协会心力衰竭专业委员会国家心血管病专家委员会心力衰竭专业委员会中华心力衰竭和心肌病杂志编辑委员. 伊伐布雷定临床应用中国专家共识J] . 中华心力衰竭和心肌病杂志,2020,4(2)84-91.
[6] Fontenla A,Tamargo J,Salgado R,et al. Ivabradine for controlling heart rate in permanent atrial fibrillation:a translational clinical trial[J]. Heart Rhythm,2023,20(6):822-830.
[7] Turley SL,Francis KE,Lowe DK,et al. Emerging role of ivabradine for rate control in atrial fibrillation[J]. Ther Adv Cardiovasc Dis,2016,10(6):348-352.
[8] Chan YH,Hai JJ,Wong CK,et al. Ventricular rate control with ivabradine in patients with permanent atrial fibrillation[J]. J Interv Card Electrophysiol,2022,65(3):597-599.
[9] Rivolta I,Binda A,Masi A,et al. Cardiac and neuronal HCN channelopathies[J]. Pflugers Arch,2020,472(7):931-951.
[10] Boyett MR,Yanni J,Tellez J,et al. Regulation of sinus node pacemaking and atrioventricular node conduction by HCN channels in health and disease[J]. Prog Biophys Mol Biol,2021,166:61-85.
[11] DiFrancesco D. The role of the funny current in pacemaker activity[J]. Circ Res,2010,106(3):434-446.
[12] Baruscotti M,Bucchi A,Viscomi C,et al. Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene HCN4[J]. Proc Natl Acad Sci U S A,2011,108(4):1705-1710.
[13] Zhou J,Ding WG,Makiyama T,et al. A novel HCN4 mutation,G1097W,is associated with atrioventricular block[J]. Circ J,2014,78(4):938-942.
[14] Chiamvimonvat V,Newman D,Tang A,et al. A double-blind placebo-controlled evaluation of the human electrophysiologic effects of zatebradine,a sinus node inhibitor[J]. J Cardiovasc Pharmacol,1998,32(4):516-520.
[15] Amstetter D,Badt F,Rubi L,et al. The bradycardic agent ivabradine decreases conduction velocity in the AV node and in the ventricles in-vivo[J]. Eur J Pharmacol,2021,893:173818.
[16] Marciszek M,Paterek A,Oknińska M,et al. Effect of ivabradine on cardiac arrhythmias:antiarrhythmic or proarrhythmic?[J].Heart Rhythm,2021,18(7):1230-1238.
[17] Novella Romanelli M,Sartiani L,Masi A,et al. HCN channels modulators:the need for selectivity[J]. Curr Top Med Chem,2016,16(16):1764-1791.
[18] Mesirca P,Alig J,Torrente AG,et al. Cardiac arrhythmia induced by genetic silencing of ’funny’ (f) channels is rescued by GIRK4 inactivation[J]. Nat Commun,2014,5:4664.
[19] Verrier RL,Sobrado MF,Pagotto VP,et al. Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone’s reduction in ventricular rate during atrial fibrillation[J]. Heart Rhythm,2013,10(11):1692-1697.
[20] Verrier RL,Silva AF,Bonatti R,et al. Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation[J]. J Cardiovasc Electrophysiol,2015,26(3):329-335.
[21] Saeed Y,Temple IP,Borbas Z,et al. Structural and functional remodeling of the atrioventricular node with aging in rats:the role of hyperpolarization-activated cyclic nucleotide-gated and ryanodine 2 channels[J]. Heart Rhythm,2018,15(5):752-760.
[22] Kosiuk J,Oebel S,John S,et al. Ivabradine for rate control in atrial fibrillation[J]. Int J Cardiol,2015,179:27-28.
[23] Caminiti G,Fossati C,Rosano G,et al. Addition of ivabradine to betablockers in patients with atrial fibrillation:effects on heart rate and exercise tolerance[J]. Int J Cardiol,2016,202:73-74.
[24] Wongcharoen W,Ruttanaphol A,Gunaparn S,et al. Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation[J]. Int J Cardiol,2016,224:252-255.
[25] Katheria A,Kapoor A,Sahu A,et al. A pilot study evaluating the role of ivabradine for rate control in patients with rheumatic atrial fibrillation[J]. Indian Heart J,2023,75(5):376-382.
[26] Agakishiev D,Arriola-Montenegro J,Tandon R,et al. Heart rate lowering for coronary CTA with ivabradine in atrial fibrillation[J]. J Cardiovasc Comput Tomogr,2024,18(1):109-110.
[27] Vora A,Kapoor A,Nair M,et al. Clinical presentation,management,and outcomes in the Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF) registry[J]. Indian Heart J,2017,69(1):43-47.
[28] Hardison E,Cox ZL,Heckman K,et al. A case report of ivabradine used for heart rate control of atrial fibrillation in acute decompensated heart failure[J]. Eur Heart J Case Rep,2022,6(2):ytac077.
[29] Fontenla A,Villagraz L,de Juan J,et al. Ivabradine as an alternative to AV node ablation in a patient with permanent atrial fibrillation[J]. Rev Esp Cardiol (Engl Ed),2017,70(11):1019-1020.
[30] Pichler P,Pichler-Cetin E,Vertesich M,et al. Ivabradine versus metoprolol for heart rate reduction before coronary computed tomography angiography[J]. Am J Cardiol,2012,109(2):169-173.
[31] Lu Y,Li K,Liu XS,et al. Ivabradine and atrial fibrillation:a double-edged sword[J]. Int J Cardiol,2016,223:182-185.
[32] Suenari K,Cheng CC,Chen YC,et al. Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis[J]. J Cardiovasc Electrophysiol,2012,23(2):200-206.
[33] Abdel-Salam Z,Nammas W. Atrial fibrillation after coronary artery bypass surgery:can ivabradine reduce its occurrence?[J]. J Cardiovasc Electrophysiol,2016,27(6):670-676.
[34] Tanbo?a ?H,Top?u S,Aksakal E,et al. The risk of atrial fibrillation with ivabradine treatment:a meta-analysis with trial sequential analysis of more than 40 000 patients[J]. Clin Cardiol,2016,39(10):615-620.
[35] Liu J,Noble PJ,Xiao G,et al. Role of pacemaking current in cardiac nodes:insights from a comparative study of sinoatrial node and atrioventricular node[J]. Prog Biophys Mol Biol,2008,96(1-3):294-304.